![Bart Cornelissen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bart Cornelissen
Director of Finance/CFO at
XENCOR, INC.
Net worth: 901 668 $ as of 2026-05-30
Profile
Bart Cornelissen currently works at Xencor, Inc., as Chief Financial Officer & Senior Vice President from 2024.
Mr. Cornelissen also formerly worked at Seagen, Inc., as Vice President-Finance.
Mr. Cornelissen received his graduate degree from Rotterdam School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
XENCOR, INC. 0.1% | 2026-04-09 | 75,898 ( 0.1% ) | 901 668 $ | 2026-05-30 |
Bart Cornelissen active positions
| Companies | Position | Start |
|---|---|---|
| XENCOR, INC. | Director of Finance/CFO | 2024-04-08 |
Former positions of Bart Cornelissen
| Companies | Position | End |
|---|---|---|
| SEAGEN INC. | Director of Finance/CFO | - |
Training of Bart Cornelissen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Rotterdam School of Management
 Rotterdam School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Bart Cornelissen
